RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,908 | -19.4% | 314,730 | -3.7% | 0.00% | – |
| Q2 2023 | $421,804 | +3.0% | 326,980 | +5.4% | 0.00% | – |
| Q1 2023 | $409,385 | -12.0% | 310,140 | 0.0% | 0.00% | – |
| Q4 2022 | $465,210 | +34.1% | 310,140 | +5.3% | 0.00% | – |
| Q3 2022 | $347,000 | +4.2% | 294,440 | 0.0% | 0.00% | – |
| Q2 2022 | $333,000 | -29.6% | 294,440 | +86.0% | 0.00% | – |
| Q1 2022 | $473,000 | +13.2% | 158,340 | +0.4% | 0.00% | – |
| Q4 2021 | $418,000 | -27.1% | 157,740 | 0.0% | 0.00% | – |
| Q3 2021 | $573,000 | -16.4% | 157,740 | 0.0% | 0.00% | – |
| Q2 2021 | $685,000 | +49.2% | 157,740 | +17.4% | 0.00% | – |
| Q1 2021 | $459,000 | -19.9% | 134,340 | -18.0% | 0.00% | – |
| Q4 2020 | $573,000 | +58.7% | 163,740 | +8.9% | 0.00% | – |
| Q3 2020 | $361,000 | -16.4% | 150,340 | -36.4% | 0.00% | – |
| Q2 2020 | $432,000 | +30.5% | 236,240 | +11.4% | 0.00% | – |
| Q1 2020 | $331,000 | -27.1% | 212,040 | 0.0% | 0.00% | – |
| Q4 2019 | $454,000 | +14.4% | 212,040 | 0.0% | 0.00% | – |
| Q3 2019 | $397,000 | -25.2% | 212,040 | +4.3% | 0.00% | – |
| Q2 2019 | $531,000 | +7.5% | 203,340 | +5.9% | 0.00% | – |
| Q1 2019 | $494,000 | -88.3% | 192,040 | -89.6% | 0.00% | -100.0% |
| Q4 2018 | $4,237,000 | -1.6% | 1,842,040 | +37.3% | 0.00% | 0.0% |
| Q3 2018 | $4,308,000 | +30.4% | 1,342,040 | +15.0% | 0.00% | +50.0% |
| Q2 2018 | $3,303,000 | +38.0% | 1,167,040 | +72.6% | 0.00% | 0.0% |
| Q1 2018 | $2,393,000 | +22.6% | 676,040 | +34.4% | 0.00% | +100.0% |
| Q4 2017 | $1,952,000 | +55.3% | 503,040 | +1.7% | 0.00% | 0.0% |
| Q3 2017 | $1,257,000 | +218.2% | 494,740 | +241.8% | 0.00% | – |
| Q2 2017 | $395,000 | +2.9% | 144,740 | +24.6% | 0.00% | – |
| Q1 2017 | $384,000 | +39.1% | 116,140 | 0.0% | 0.00% | – |
| Q4 2016 | $276,000 | -35.2% | 116,140 | 0.0% | 0.00% | – |
| Q3 2016 | $426,000 | +64.5% | 116,140 | 0.0% | 0.00% | – |
| Q2 2016 | $259,000 | +9.7% | 116,140 | +2.6% | 0.00% | – |
| Q1 2016 | $236,000 | -31.2% | 113,240 | 0.0% | 0.00% | – |
| Q4 2015 | $343,000 | +21.6% | 113,240 | -0.9% | 0.00% | – |
| Q3 2015 | $282,000 | -70.1% | 114,240 | -61.1% | 0.00% | -100.0% |
| Q2 2015 | $943,000 | -8.2% | 293,720 | +2.1% | 0.00% | 0.0% |
| Q1 2015 | $1,027,000 | +57.3% | 287,720 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $653,000 | +16.4% | 287,720 | -0.6% | 0.00% | – |
| Q3 2014 | $561,000 | -46.6% | 289,420 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $1,051,000 | -8.6% | 289,420 | -2.3% | 0.00% | 0.0% |
| Q1 2014 | $1,150,000 | +36.1% | 296,341 | -0.1% | 0.00% | 0.0% |
| Q4 2013 | $845,000 | -28.3% | 296,596 | -9.9% | 0.00% | 0.0% |
| Q3 2013 | $1,178,000 | +7.8% | 329,096 | +0.5% | 0.00% | 0.0% |
| Q2 2013 | $1,093,000 | – | 327,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |